Human papillomavirus (HPV) is the main etiological factor for cervical cancer development.
HPV is also associated with other anogenital and oropharyngeal tumors. HPV associated
tumors are frequent and constitute a public health problem, mainly in developing countries.
Therapy against such tumors is usually excisional, causing iatrogenic morbidity. Therefore,
development of strategies for new therapies is desirable. The tumor microenvironment is
essential for tumor growth, where inflammation is an important component, displaying a …